GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Conatus Pharmaceuticals Inc (NAS:CNAT) » Definitions » Book Value per Share

Conatus Pharmaceuticals (Conatus Pharmaceuticals) Book Value per Share : $0.53 (As of Mar. 2020)


View and export this data going back to 2013. Start your Free Trial

What is Conatus Pharmaceuticals Book Value per Share?

Conatus Pharmaceuticals's book value per share for the quarter that ended in Mar. 2020 was $0.53.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the book value growth rate using book value per share data.

Conatus Pharmaceuticals's current price is $0.56. Its book value per share for the quarter that ended in Mar. 2020 was $0.53. Hence, today's PB Ratio of Conatus Pharmaceuticals is 1.05.


Conatus Pharmaceuticals Book Value per Share Historical Data

The historical data trend for Conatus Pharmaceuticals's Book Value per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Conatus Pharmaceuticals Book Value per Share Chart

Conatus Pharmaceuticals Annual Data
Trend Dec11 Dec12 Dec13 Dec14 Dec15 Dec16 Dec17 Dec18 Dec19
Book Value per Share
Get a 7-Day Free Trial Premium Member Only 1.74 0.83 0.93 0.83 0.61

Conatus Pharmaceuticals Quarterly Data
Jun15 Sep15 Dec15 Mar16 Jun16 Sep16 Dec16 Mar17 Jun17 Sep17 Dec17 Mar18 Jun18 Sep18 Dec18 Mar19 Jun19 Sep19 Dec19 Mar20
Book Value per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.71 0.73 0.66 0.61 0.53

Competitive Comparison of Conatus Pharmaceuticals's Book Value per Share

For the Biotechnology subindustry, Conatus Pharmaceuticals's PB Ratio, along with its competitors' market caps and PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Conatus Pharmaceuticals's PB Ratio Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Conatus Pharmaceuticals's PB Ratio distribution charts can be found below:

* The bar in red indicates where Conatus Pharmaceuticals's PB Ratio falls into.



Conatus Pharmaceuticals Book Value per Share Calculation

Conatus Pharmaceuticals's Book Value Per Share for the fiscal year that ended in Dec. 2019 is calculated as:

Book Value Per Share=(Total Stockholders Equity-Preferred Stock)/Shares Outstanding (EOP)
=(20.19-0.00)/33.17
=0.61

Conatus Pharmaceuticals's Book Value Per Share for the quarter that ended in Mar. 2020 is calculated as:

Book Value Per Share=(Total Stockholders Equity-Preferred Stock)/Shares Outstanding (EOP)
=(17.64-0.00)/33.17
=0.53

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Theoretically it is what the shareholders will receive if the company is liquidated. Total Stockholders Equity is a balance sheet item and equal to Total Assets less Total Liabilities of the company.

Book value may include intangible items which may come from the company's past acquisitions. Book value less intangibles is called Tangible Book.


Conatus Pharmaceuticals  (NAS:CNAT) Book Value per Share Explanation

Usually a company's book value and Tangible Book per Share may not reflect its true value. The assets may be carried on the balance sheets at the original cost minus depreciation. This may underestimate the true economic values of the assets. It also may over-estimate their true economic value because the assets can become obsolete.

For financial companies such as banks and insurance companies, their assets may be reported in current market value of the assets owned. Book values of financial companies are more accurate indicator of the economic value of the company.


Conatus Pharmaceuticals Book Value per Share Related Terms

Thank you for viewing the detailed overview of Conatus Pharmaceuticals's Book Value per Share provided by GuruFocus.com. Please click on the following links to see related term pages.


Conatus Pharmaceuticals (Conatus Pharmaceuticals) Business Description

Traded in Other Exchanges
N/A
Address
16745 West Bernardo Drive, Suite 250, San Diego, CA, USA, 92127
Conatus Pharmaceuticals Inc is a biotechnology company focused on the development and commercialization of novel medicines to treat chronic diseases with significant unmet need. The company is developing emricasan, an orally active pan-caspase inhibitor, for the treatment of patients with chronic liver disease. Emricasan is designed to reduce the activities of human caspases, which are enzymes that mediate inflammation and apoptosis. Conatus has also been developing CTS-2090, an orally active selective caspase inhibitor, for diseases involving inflammasome pathways.